【绿叶制药(02186.HK):罗替高汀贴片Rotigotine Luye在英国上市】绿叶制药(02186.HK)发布公告,集团开发的罗替高汀贴片Rotigotine Luye已于近期在英国上市,用于治疗早期和晚期特发性帕金森病的体征和症状,以及用于治疗中重度特发性不宁腿综合征。该产品是首款在英国上市的Neupro®的仿制药,与Neupro®具有生物等效性。

金融界
10 Apr
绿叶制药(02186.HK)发布公告,集团开发的罗替高汀贴片Rotigotine Luye已于近期在英国上市,用于治疗早期和晚期特发性帕金森病的体征和症状,以及用于治疗中重度特发性不宁腿综合征。该产品是首款在英国上市的Neupro®的仿制药,与Neupro®具有生物等效性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10